自拟流感方治疗儿童乙型流感的疗效及血清学研究

金海燕; 詹璐; 许斌斌; 田浦任

doi:10.16766/j.cnki.issn.1674-4152.002416

自拟流感方治疗儿童乙型流感的疗效及血清学研究

doi: 10.16766/j.cnki.issn.1674-4152.002416

1.
浙江省中西医结合医院儿科，浙江杭州 310003
2.
嘉善县中医医院儿科，浙江嘉兴 314100

基金项目:

浙江省中医药科技计划项目 20192B091

详细信息

通讯作者:
詹璐，E-mail: 273427705@qq.com

中图分类号: R511.7 R289.54
计量
- 文章访问数: 161
- HTML全文浏览量: 98
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2021-04-25
- 网络出版日期: 2022-08-20

Efficacy and serological study of self-designed influenza formula in treating influenza B in children

1.
Department of Pediatric, Zhejiang Integrated Traditional and Western Medicine Hospital, Hangzhou, Zhejiang 310003, China

摘要

摘要: 目的观察自拟流感方治疗儿童乙型流感的临床疗效及其对血清学IL-6、γ-干扰素(IFN-γ)的影响。方法选择2019年1月—2020年2月就诊于浙江省中西医结合医院儿科门诊符合纳入标准的乙型流感患儿60例，按随机数表法分为观察组及对照组，各30例，2组均予以对症支持治疗的同时，观察组给予口服自拟流感方, 对照组予口服奥司他韦，疗程均为5 d，记录并比较2组组间及治疗前后组内血清IL-6及IFN-γ的差异。结果治疗5 d后，观察组脱落2例，对照组脱落1例，观察组总有效率为96.4%，高于对照组的72.4%(P < 0.05)。治疗前2组血清IL-6及IFN-γ水平差异无统计学意义，2组组内治疗前后IL-6及IFN-γ比较差异有统计学意义(均P < 0.05)；治疗后观察组IL-6为0.53(0.36，0.66)ng/L，低于对照组的0.69(0.46，1.37)ng/L，观察组IFN-γ水平为3.47(1.96，5.90)ng/L，低于对照组的5.07(2.38，13.12)ng/L, 差异均有统计学意义(均P < 0.05)。结论自拟流感方能有效治疗儿童乙型流感，改善临床症状，并降低血清IL-6、IFN-γ水平，其作用机制可能通过降低IL-6、IFN-γ炎症因子水平来发挥作用。
- 流感方 /
- 乙型流感 /
- 白细胞介素6 /
- γ-干扰素
Abstract: Objective To observe the clinical efficacy of self-made influenza formula in the treatment of influenza B in children and its effect on serological Interleukin 6 (IL-6) and Interferon-γ (IFN-γ). Methods Total 60 in the standard cases of children with influenza B were selected from the Pediatric Outpatient of Zhejiang Integrated Traditional and Western Medicine Hospital from January 2019 to February 2020. They were equally divided into observation and control groups according to the random-number table method, 30 cases in each group. Both groups supported symptomatic treatment. At the same time, the observation group was given oral self-made influenza formula and the control group was given oral oseltamivir for 5 days. The serum IL-6 and IFN- γ between the two groups and before and after treatment were recorded and compared. Results After 5 days of treatment, 2 cases of leakage were found in the observation group, and 1 case of leakage was found in the control group. The total effective rate of the observation group was 96.4%, higher than the 72.4% in the control group (P < 0.05). Before treatment, no difference in serum IL-6 and IFN-γ levels were found between the two groups, and the differences in IL-6 and IFN-γ before and after treatment were statistically significant (all P < 0.05). After treatment, the IL-6 level in the observation group was 0.53(0.36, 0.66) ng/L, which was lower than that in the control group [0.69(0.46, 1.37) ng/L], and the IFN-γ level in the observation group was 3.47(1.96, 5.90) ng/L, which was lower than that in the control group [5.07(2.38, 13.12) ng/L], with statistically significant differences (all P < 0.05). Conclusion Self-designed influenza can effectively treat influenza B in children, improve clinical symptoms, and reduce serum levels of IL-6 and IFN-γ. We speculate that its mechanism may play a role by reducing the levels of IL-6 and IFN-γ inflammatory factors.
- Influenza formula /
- Influenza B /
- Interleukin 6 /
- Interferon-γ

HTML全文

表 1 2组乙流患儿性别、年龄比较

Table 1. Comparison of gender and age between two groups of children with influenza B

组别	例数	性别(例)		年龄(x±s，岁)
组别	例数	男	女	年龄(x±s，岁)
观察组	28	14	14	7.89±2.06
对照组	29	12	17	8.00±1.95
注：2组性别比较，χ²=0.427，P=0.514；年龄比较，t=0.385，P=0.537。

下载: 导出CSV

表 2 2组乙流患儿总有效率比较

Table 2. Comparison of total effective rate between two groups of children with influenza B

组别	例数	痊愈(例)	显效(例)	有效(例)	无效(例)	总有效率(%)
观察组	28	13	9	5	1	96.4(27/28)
对照组	29	8	6	7	8	72.4(21/29)
注：2组总有效率比较，χ²=4.505，P=0.034。

下载: 导出CSV

表 3 2组乙流患儿治疗前后IFN-γ水平比较[M(P₂₅, P₇₅)，ng/L]

Table 3. Comparison of IFN-γ levels before and after treatment in two groups of children with influenza B [M(P₂₅, P₇₅), ng/L]

组别	例数	治疗前	治疗后	Z值	P值
观察组	28	7.29(3.30, 16.25)	3.47(1.96, 5.90)	4.577	＜0.001
对照组	29	6.34(2.98, 16.41)	5.07(2.38, 13.12)	4.703	＜0.001
Z值		0.072	1.979
P值		0.943	0.048

下载: 导出CSV

表 4 2组乙流患儿治疗前后IL-6水平比较[M(P₂₅, P₇₅)，ng/L]

Table 4. Comparison of IL-6 levels before and after treatment in two groups of children with influenza B [M(P₂₅, P₇₅), ng/L]

组别	例数	治疗前	治疗后	Z值	P值
观察组	28	0.91(0.63, 1.55)	0.53(0.36, 0.66)	4.623	＜0.001
对照组	29	0.81(0.54, 1.61)	0.69(0.46, 1.37)	4.703	< 0.001
Z值		0.535	2.426
P值		0.593	0.015

下载: 导出CSV

参考文献(16)

[1]	付小康, 李全瑞. 2018—2019跨年期间流感样病例病原监测12 369例分析[J]. 中国临床医生杂志, 2019, 47(11): 1361-1363. doi: 10.3969/j.issn.2095-8552.2019.11.033 FU X K, LI Q R. Analysis of 12 369 cases of influenza-like disease pathogen surveillance during 2018-2019[J]. Chinese journal of clinician, 2019, 47(11): 1361-1363. doi: 10.3969/j.issn.2095-8552.2019.11.033
[2]	付惠玲, 韩长青, 焦书真, 等. 2017年冬季本院甲乙型流感患儿的临床特点[J]. 临床医学研究与实践, 2019, 4(8): 82-85. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS201908032.htm FU H L, HAN C Q, JIAO S Z, et al. Clinical characteristics of children with influenza A and B in our hospital in winter of 2017[J]. Clinical medical research and practice, 2019, 4(8): 82-85. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS201908032.htm
[3]	中华人民共和国卫生健康委员会. 流行性感冒诊疗方案(2018年版修订版)[J]. 传染病信息, 2018, 31(6): 500-504. doi: 10.3969/j.issn.1007-8134.2018.06.002 Health Commission of the People ' s Republic of China. Protocol for diagnosis and treatment of influenza(2018 revised version)[J]. Infectious Disease Information, 2018, 31(6): 500-504. doi: 10.3969/j.issn.1007-8134.2018.06.002
[4]	KOUTSAKOS M, NGUYEN T H, BARCLAY W S, et al. Knowns and unknowns of influenza B viruses[J]. Future Microbiol, 2016, 11(1): 119-135. doi: 10.2217/fmb.15.120
[5]	WAN S W, WU-HSIEH B A, LIN Y S, et al. The monocyte-macrophage-mast cell axis in dengue pathogenesis[J]. J Biomed Sci, 2018, 25(1): 77-87. doi: 10.1186/s12929-018-0482-9
[6]	于卓男, 林树鹏, 顾立刚, 等. 川芎嗪对甲型流感病毒H1N1诱导炎性细胞因子分泌作用的研究[J]. 中华中医药杂志, 2017, 32(6): 2680-2683. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201706095.htm YU Z N, LIN S P, GU L G, et al. Research of ligustrazine on influenza virus H1Nl-induced the secretion of inflammatory cytokines[J]. Chinese journal of traditional Chinese medicine, 2017, 32(6): 2680-2683. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201706095.htm
[7]	LIU B, BAO L, WANG L, et al. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice[J]. J Microbiol Immunol Infect, 2021, 54(3): 396-403. doi: 10.1016/j.jmii.2019.07.009
[8]	孙文英, 李莎莎, 闫一兵. 热性惊厥患儿血清白细胞介素-6及10水平变化[J]. 中华实用诊断与治疗杂志, 2016, 30(7): 699-700. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201607026.htm SUN W Y, LI S S, YAN Y B. Changes of serum interleukin-6 and interleukin-10 in children with febrile seizures[J]. Chin J prin - diagnosis & therapy, 2016, 30(7): 699-700. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201607026.htm
[9]	BETAKOVA T, KOSTRABOVA A, LACHOVA V, et al. Cytokines induced during influenza virus infection[J]. Curr Pharm Des, 2017, 23(18): 2616-2622.
[10]	陈刚, 陈红卫, 潘砚鹏, 等. 急性A型主动脉夹层并发肺损伤患者血清CRP、IL-6水平分析[J]. 中国现代医药杂志, 2020, 22(7): 54-56. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHTY202007023.htm CHEN G, CHEN H W, PAN Y P, et al. Serum levels of CRP and IL-6 in patients with acute type A aortic dissection complicated with lung injury[J]. Chinese journal of contemporary medicine, 2020, 22(7): 54-56. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHTY202007023.htm
[11]	樊江平, 刘成, 姜彩肖. IL-1β、IL-6、IFN-γ在甲型H1N1流感病毒性肺炎患者血清中的表达及其与疾病预后的相关性分析[J]. 临床肺科杂志, 2020, 25(6): 816-819, 901. doi: 10.3969/j.issn.1009-6663.2020.06.002 FAN J P, LIU C, JIANG C X. Expressions of IL-1β, IL-6 and IFN-γin the serum of patients with influenza A H1N1 influenza virus pneu-monia and their correlation with disease prognosis[J]. Journal of clinical pulmonol, 2020, 25(6): 816-819, 901. doi: 10.3969/j.issn.1009-6663.2020.06.002
[12]	王勇, 王艺霏, 马骥, 等. 连花清瘟胶囊联合奥司他韦治疗儿童流感病毒感染疗效及对NO、IFN-γ、IL-17表达水平的影响[J]. 中华中医药学刊, 2020, 38(1): 214-216. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202001053.htm WANG Y, WANG Y F, MA J, et al. Efficacy of lianhua qingwen capsule combined with oseltamivir in treatment of influenza virus infection in children and its effect on the expression of NO, IFN-γand IL-17[J]. Chinese journal of traditional Chinese medicine, 2020, 38(1): 214-216. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202001053.htm
[13]	杨金亮, 刘畅, 齐文升. 流行性感冒的中医预防研究[J]. 中医学报, 2018, 33(9): 1679-1681. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201809020.htm YANG J L, LIU C, QI W S. Study on prevention of influenza with traditional Chinese Medicine[J]. Journal of traditional Chinese medicine, 2018, 33(9): 1679-1681. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201809020.htm
[14]	吕小琴, 李敏, 刘清泉. 流行性感冒不同病原的中医病证研究[J]. 中国中医急症, 2020, 29(1): 61-64. doi: 10.3969/j.issn.1004-745X.2020.01.016 LYU X Q, LI M, LIU Q Q. Study on TCM syndrome of different etiology of influenza[J]. Chinese journal of TCM emergency, 2020, 29(1): 61-64. doi: 10.3969/j.issn.1004-745X.2020.01.016
[15]	YANG L, CHEN J, LU H, et al. Pueraria lobata for diabetes mellitus: Past, present and future[J]. Am J Chinese Med, 2019, 47(7): 1419-1444. doi: 10.1142/S0192415X19500733
[16]	姚玉乔, 高映, 彭财英, 等. 竹叶柴胡化学成分及药理活性的研究进展[J]. 安徽医药, 2019, 23(10): 1913-1916. doi: 10.3969/j.issn.1009-6469.2019.10.002 YAO Y Q, GAO Y, PENG C Y, et al. Progress in studies on chemical constituents and pharmacological effects of Bupleurum marginatum[J]. Anhui medicine, 2019, 23(10): 1913-1916. doi: 10.3969/j.issn.1009-6469.2019.10.002